Published in Ciba Found Symp on January 01, 1997
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Global biodiversity conservation priorities. Science (2006) 11.20
Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08
Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med (2000) 3.26
Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol (2001) 3.05
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67
Contrast, induction, facilitation, suppression, and conservation. J Exp Anal Behav (1976) 2.50
CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46
Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol (2001) 2.41
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (1995) 2.40
Immune response restoration with macrophage culture supernatants. Science (1971) 2.37
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24
Tolerance of class I histocompatibility antigens expressed extrathymically. Nature (1989) 2.19
Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes (1997) 2.19
Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction (1994) 2.11
Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J (1999) 2.04
The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. Cell (1983) 2.04
The effect of aortic valve replacement on survival. Circulation (1982) 2.03
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98
The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol (1999) 1.97
Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature (1992) 1.92
Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature (1990) 1.87
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83
Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today (1998) 1.82
Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin. Diabetologia (2008) 1.79
Self-ignorance in the peripheral T-cell pool. Immunol Rev (1993) 1.73
Postoperative cognitive deficit in the elderly surgical patient. Br J Anaesth (1998) 1.72
The antigen specificity of thymus-derived helper cells. J Immunol (1972) 1.70
Rapid telomere movement in meiotic prophase is promoted by NDJ1, MPS3, and CSM4 and is modulated by recombination. Cell (2008) 1.69
Induction of autoimmune diabetes by oral administration of autoantigen. Science (1996) 1.69
Two subsets of epithelial cells in the thymic medulla. J Exp Med (1992) 1.59
Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis (1988) 1.58
Regulation of the immune response. II. Qualitative and quantitative differences between thymus- and bone marrow-derived lymphocytes in the recognition of antigen. J Exp Med (1973) 1.57
Activation and migration of CD8 T cells in the intestinal mucosa. J Immunol (1997) 1.56
CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55
Neural interaction of the amygdala with the prefrontal and temporal cortices in the processing of facial expressions as revealed by fMRI. J Cogn Neurosci (2001) 1.54
The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review. Pharmacoepidemiol Drug Saf (2013) 1.53
Stoichiometry of the reaction of oxyhemoglobin with nitrite. Biochim Biophys Acta (1979) 1.53
Visceral adipose tissue and cardiovascular risk factors in obese children. J Pediatr (1998) 1.49
Effect of physical training on total and visceral fat in obese children. Med Sci Sports Exerc (1999) 1.48
The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47
Peripheral T cell tolerance. Annu Rev Immunol (1992) 1.47
Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis. J Eur Acad Dermatol Venereol (2009) 1.47
Paired baseline performance as a behavioral ideal. J Exp Anal Behav (1981) 1.46
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci U S A (1989) 1.44
The nu gene acts cell-autonomously and is required for differentiation of thymic epithelial progenitors. Proc Natl Acad Sci U S A (1996) 1.43
Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs. Arthritis Rheum (2007) 1.43
Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43
Clonal deletion of autospecific B lymphocytes. Immunol Rev (1991) 1.42
An idiotypic determinant formed by both immunoglobulin constant and variable regions. Nature (1983) 1.42
The discovery of the immunological function of the thymus. Immunol Today (1991) 1.42
Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol (1995) 1.40
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
An approach to locate phosphorylation sites in a phosphoprotein: mass mapping by combining specific enzymatic degradation with matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem (1994) 1.38
Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun (2000) 1.38
Peritoneal macrophages in the immune response to SRBC in vitro. Immunology (1970) 1.35
Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. J Exp Med (1989) 1.35
RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol (1996) 1.32
Fat distribution and hemostatic measures in obese children. Am J Clin Nutr (1998) 1.31
Partial nucleotide sequence of human calcitonin precursor mRNA identifies flanking cryptic peptides. Nature (1982) 1.31
Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity (2001) 1.29
Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose? J Virol (1998) 1.28
HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens (2003) 1.28
Enhanced detection of phosphopeptides in matrix-assisted laser desorption/ionization mass spectrometry using ammonium salts. J Am Soc Mass Spectrom (1999) 1.26
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult Scler (2006) 1.25
Immunological tolerance: new approaches using transgenic mice. Immunol Today (1989) 1.25
The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur J Immunol (1990) 1.25
Production of RNA for secreted immunoglobulin mu chains does not require transcriptional termination 5' to the microM exons. Nature (1983) 1.24
Catheter ablation of atrial flutter guided by electroanatomic mapping (CARTO): a randomized comparison to the conventional approach. J Cardiovasc Electrophysiol (2000) 1.23
Regulation of the immune response. I. Differential effect of passively administered antibody on the thymus-derived and bone marrow-derived lymphocytes. J Exp Med (1971) 1.23
Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature (1999) 1.23
Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes. Diabetologia (2007) 1.23
Constitutive and strong association of PAF53 with RNA polymerase I. Chromosoma (1997) 1.22
Individual trait anxiety levels characterizing the properties of zen meditation. Neuropsychobiology (2004) 1.21
Tolerance induction by thymic medullary epithelium. Proc Natl Acad Sci U S A (1992) 1.21
B cells directly tolerize CD8(+) T cells. J Exp Med (1998) 1.20
SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens (2006) 1.20